معرفی
Sandra Hakim is a Research Fellow at Monash University's School of Primary and Allied Health Care, specializing in molecular mechanisms underlying kidney diseases. Her work focuses on polycystic kidney disease (PKD), investigating signaling pathways such as AKT, beta-catenin, and INPP5E. She also explores phosphoinositide signaling and primary cilia function in disease progression.
Projects: She served as Project Manager for the Understanding the Diagnosis and Treatment of Secondary Hypertension (U-DASH Study) (2024), addressing hypertension management strategies. Her research aligns with UN Sustainable Development Goals, particularly in health and well-being.
Research Interests: Dr. Hakim’s interdisciplinary work integrates cell biology, genetics, and molecular pathology. Key areas include PKD pathogenesis, signaling pathways (PI3K/Akt/mTORC1), and the role of INPP5E in cilia stability. Her studies aim to uncover therapeutic targets for genetic and metabolic disorders.
Grants & Funding: Her involvement in the U-DASH Study suggests active grant support for translational research. No specific grant details are provided in the text.
Labs/Teams: While no specific lab affiliations are listed, her collaborations include researchers like Mitchell C.A. and Conduit S.E., indicating interdisciplinary team-based research.
